(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TMB PLUS2

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TMB PLUS2

ST13

US500000079352809

Class

1, 5

Filing

79352809

Registration

7307324

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

03/20/2026

Trademark type

Word

Nice classes

1, 5

Filing date

08/31/2022

Registration date

02/20/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/20/2024

Last transaction

03/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

65

Owner location

DK

Examiner

BROWN, TINA

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Kementec Solutions A/S

Representatives

Katherine A. Markert MARKERT & COMINOLLI PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations and chemical reagents for non-medical purposes for scientific or research use; diagnostic preparations and chemical reagentsother than for medical or veterinary purposes; diagnostic preparations and chemical and diagnostic reagents for clinical or medical laboratory use; diagnostic preparations for scientific or research use and chemical reagents for non-medical purposes for in vitro use in biochemistryclinical chemistry and microbiology; enzymes for industrial purposes; enzyme stabilizers and substrates; enzymes for scientific and research purposes; laboratory chemicalsantibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; biochemical preparations and substances for in vitro scientific and research usebiochemicals for in vitro and in vivo scientific usebiochemical preparations for scientific purposes and biochemical reagents used for non-medical purposes; biological preparations for use in cell cultures other than for medical or veterinary use; cell growth media for growing cells for scientific and research use; chromatography chemicals; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; reagent kits comprising generic DNA circleDNA primerspolymerase and buffers for use in biotechnology fields; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplificationanalysis or labelling of nucleic acid; chemicals for use in the purification of proteins for in vitro use; biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research

Class 5

Diagnostic preparations and chemical reagents for medical or veterinary purposes; medical and veterinary diagnostic reagents; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; diagnostic media for bacteriological cultures; cell growth media for growing cells for medical or clinical use; nucleic acid sequences and chemical reagents for medical and veterinary purposes

Publications

History of USPTO decisions and trademark events.

38 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/19/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/30/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/25/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/25/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/25/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/25/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/27/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/06/2024

FIMP

FINAL DISPOSITION PROCESSED

07/06/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/21/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/20/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/05/2023

PUBO

PUBLISHED FOR OPPOSITION

12/05/2023

GPNX

NOTIFICATION PROCESSED BY IB

12/03/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/15/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/15/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/31/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/31/2023

RFNT

REFUSAL PROCESSED BY IB

10/04/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/05/2023

GNRT

NON-FINAL ACTION E-MAILED

09/05/2023

CNRT

NON-FINAL ACTION WRITTEN

09/05/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/23/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/23/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/23/2023

RFNT

REFUSAL PROCESSED BY IB

08/15/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/27/2023

RFRR

REFUSAL PROCESSED BY MPU

07/22/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/19/2023

CNRT

NON-FINAL ACTION WRITTEN

06/18/2023

DOCK

ASSIGNED TO EXAMINER

06/16/2023

MAFR

APPLICATION FILING RECEIPT MAILED

10/25/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/21/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/20/2022

Continuous trademark protection

Get notified about every new filing that threatens TMB PLUS2 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.